Maxim raised the firm’s price target on Rezolute (RZLT) to $20 from $15 and keeps a Buy rating on the shares.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RZLT:
- Rezolute’s Promising Progress and Financial Strength Justify Buy Rating
- Rezolute’s Promising Outlook: Buy Rating Affirmed Amid Strategic Advancements and Strong Clinical Progress
- Rezolute, Inc. Reports Fiscal 2025 Financial Results
- Rezolute reports Q4 EPS (26c), consensus (23c)
- Rezolute, Inc. (RZLT) Q4 Earnings Cheat Sheet